Read + Share
Miller KD, Thomas A, Althouse S, Zang Y, et al. A phase 1 study of ASTX727 plus talazoparib in patients with triple-negative or
hormone resistant/HER2-negative metastatic breast cancer. Cancer 2026;132:e70407.
PMID: 41980055
|
 |
|
Miller KD, Thomas A, Althouse S, Zang Y, et al. A phase 1 study of ASTX727 plus talazoparib in patients with triple-negative or
hormone resistant/HER2-negative metastatic breast cancer. Cancer 2026;132:e70407.
PMID: 41980055
|
|
|
|